Prolactin Releasing Peptide (1-31), human, is a high-affinity GPR10 ligand that induces prolactin release. Human and rat Prolactin Releasing Peptide (1-31) bind to GPR10 with K_i values of 1.03 nM and 0.33 nM, respectively.
FW 34569 is an enkephalin analogue. It stimulated growth hormones and prolactin release and inhibited the release of cortisol and LH, while FSH remained unchanged.
Lisuride is an orally active agonist of dopamine D2 receptors, classified as an ergot derivative. It is utilized for research purposes relating to Parkinson's disease, migraine, and elevated prolactin levels [1] [2].
Cabergoline diphosphate is a dopamine D2 receptor agonist used for prolactinoma treatment. Cabergoline permits rapid and effective hormonal and tumor control by normalizing prolactin-producing pituitary adenomas levels.
RFRP-1(human) TFA, an endogenous NPFF receptor agonist, exhibits potent activity with EC50 values of 0.0011 nM for NPFF2 and 29 nM for NPFF1. It significantly diminishes the contractile function of isolated rat and rabbit cardiac myocytes. Moreover, it decreases heart rate, stroke volume, ejection fraction, and cardiac output, while elevating plasma prolactin levels in rats.